The thin film drug manufacturing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Thin Film Drug Manufacturing Market, 2024 report by The Business Research
Company offers comprehensive insights into the current state of the market and
highlights future growth opportunities.
Market Size -
The thin film drug manufacturing market size has grown strongly in recent
years. It will grow from $7.33 billion in 2023 to $7.98 billion in 2024 at a
compound annual growth rate (CAGR) of 8.9%. The growth in the historic period
can be attributed to increasing patient demand for convenient drug delivery,
the growing prevalence of chronic diseases, regulatory approvals for innovative
dosage forms, rising healthcare costs and demand for cost-effective solutions,
and enhancing the bioavailability and efficacy of thin film formulations.
The thin film drug manufacturing market size is expected to see strong growth
in the next few years. It will grow to $11.28 billion in 2028 at a compound
annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be
attributed to the increasing prevalence of chronic conditions, advancements in
formulation science and materials engineering, rising demand for personalized
and targeted drug delivery, supportive regulatory pathways and favorable
reimbursement policies, and increasing adoption of e-commerce for drug
distribution. Major trends in the forecast period include advancements in smart
and responsive drug delivery systems, increased focus on combining multiple
drugs in a single film, the evolution of more sustainable and eco-friendly
manufacturing processes, the integration of digital technologies with thin film
drug delivery, and the development of innovative solutions for taste masking
and improved patient experience.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/thin-film-drug-manufacturing-global-market-report
Scope Of Thin Film Drug Manufacturing Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Thin Film Drug Manufacturing Market Overview
Market Drivers -
The increase in the global elderly population is expected to propel the growth
of the thin-film drug manufacturing market going forward. The rise in the
global elderly population is influenced by extended life expectancies, medical
advancements, improved nutrition and healthcare, and changes in family
structures and societal norms. Thin film drug manufacturing helps meet the
needs of the growing elderly population by offering improved medication
adherence, ease of use, precise dosage control, rapid dissolution, and enhanced
stability, which together supports better management of chronic conditions and
overall health in older adults. For instance, in January 2024, according to the
Population Reference Bureau, a US-based nonprofit organization, the number of Americans
ages 65 and older is projected to increase from 58 million in 2022 to 82
million by 2050. Therefore, the increase in the global elderly population is
driving the thin film drug manufacturing market.
Market Trends -
Major companies operating in the thin film drug manufacturing market are
focusing on developing innovative products, such as oral thin film
technologies, to enhance patient compliance and ease of use. Oral thin film
technologies involve creating rapidly dissolving films that deliver medication
through the mucous membranes in the mouth for quick absorption. These films
offer a convenient, effective, and user-friendly alternative to traditional
oral dosage forms such as tablets and capsules. For instance, in April 2023,
IntelGenx Corporation, a Canada-based pharmaceutical company, announced the
Food and Drug Administration (FDA) approval of RIZAFILM for the treatment of
acute migraine. This new formulation allows for rapid dissolution and
absorption, potentially providing faster relief for migraines compared to
traditional tablets. This innovation enhances bioavailability and offers a more
convenient, user-friendly option, improving patient compliance. The thin film
technology enhances patient compliance and ease of use, making it a more user-friendly
alternative for managing acute migraine attacks.
The thin film drug manufacturing market covered in this report is segmented –
1) By Type: Oral Thin Film, Transdermal Film, Other Types
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea
And Vomiting, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail
Pharmacies, E-Commerce
Get an inside scoop of the thin film drug manufacturing market, Request now for
Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19730&type=smp
Regional Insights -
North America was the largest region in the thin film drug manufacturing market
in 2023. The regions covered in the thin film drug manufacturing market report
are Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East, Africa.
Key Companies -
Major companies operating in the thin film drug manufacturing market are
Novartis AG, Merck KGaA, Dr. Reddy's Laboratories, Indivior PLC, LTS Lohmann
Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark,
AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma
Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film
Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL
Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.< /b>
Table of Contents
1. Executive Summary
2. Thin Film Drug Manufacturing Market Report Structure
3. Thin Film Drug Manufacturing Market Trends And Strategies
4. Thin Film Drug Manufacturing Market – Macro Economic Scenario
5. Thin Film Drug Manufacturing Market Size And Growth
…..
27. Thin Film Drug Manufacturing Market Competitor Landscape And Company
Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment